Currently Browsing
Our Products
Aurobindo Receives FDA Approval for Niacin Extended-Release Tablets USP
Overview
- Reference Brand:
- Therapeutic Class:
Specifications
Order Information
Attributes
- Physical Form:
January 02, 2025 | Aurobindo Receives FDA Approval for Glycopyrrolate Oral Solution, 1 mg/5 mL ... Read more
December 26, 2024 | Aurobindo Receives FDA Approval for Deutetrabenazine Tablets, 6 mg, 9 mg, and 12 mg ... Read more
December 12, 2024 | Aurobindo Receives FDA Approval for Clozapine Orally Disintegrating Tablets, 12.5 mg, 25 mg, 100 mg, 150 mg, and 200 mg ... Read more